ArticleCancer chemotherapy and pharmacology2026

Window of opportunity study measuring defactinib and avutometinib delivery in glioblastomas.

Miguel Mayol Del Valle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.